Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.3 USD
-0.26%
Market Closed
Updated:
May 13, 2024
Taro Pharmaceutical Industries Ltd
Total Other Income
|
Taro Pharmaceutical Industries Ltd
Total Other Income Peer Comparison
Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Total Other Income
$3.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Total Other Income
-$66m
|
CAGR 3-Years
-304%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Total Other Income
-$964k
|
CAGR 3-Years
9%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Total Other Income
-₪1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Total Other Income?
Total Other Income
3.9m
USD
3.9m
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Total Other Income amounts to 3.9m USD.
What is Taro Pharmaceutical Industries Ltd's Total Other Income growth rate?
Total Other Income CAGR 10Y
5%
5%
Over the last year, the Total Other Income growth was 107%. The average annual Total Other Income growth rates for Taro Pharmaceutical Industries Ltd have been 3% over the past three years , 10% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
